These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

18 related articles for article (PubMed ID: 33390555)

  • 1. Effect of carrageenan-induced acute peripheral inflammation on the pharmacokinetics and hepatic metabolism of midazolam in rats.
    Kajikawa N; Doi M; Kusaba J; Aiba T
    Drug Metab Pharmacokinet; 2014; 29(5):400-6. PubMed ID: 24717840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Bu-Zhong-Yi-Qi-Tang on hepatic drug-metabolizing enzymes and plasma tolbutamide concentration in rats.
    Yao HT; Chang YW; Uramaru N; Watanabe Y; Kitamura S; Kuo YH; Lii CK; Yeh TK
    J Ethnopharmacol; 2012 Jun; 142(1):121-8. PubMed ID: 22564357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of carrageenan-induced acute peripheral inflammation on the electrolyte disposition to cerebrospinal fluid in rats.
    Kono K; Okada A; Ishikawa A; Aiba T
    Biol Pharm Bull; 2013; 36(11):1829-34. PubMed ID: 24189427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of carbon tetrachloride-induced hepatic injury on stereoselective N-demethylation of chlorpheniramine by rat hepatic cytochrome P450 2C11 isozyme].
    Nomura A; Sakurai E; Hikichi N
    Yakugaku Zasshi; 1998 Aug; 118(8):317-23. PubMed ID: 9739616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of carrageenan-induced inflammation on the induction of hepatic microsomal enzymes by phenobarbital and benzo[a]pyrene in male rats.
    Ishikawa M; Sasaki K; Takayanagi Y; Sasaki K
    J Pharmacobiodyn; 1992 Apr; 15(4):139-46. PubMed ID: 1494976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute Peripheral Inflammation Increases Plasma Concentration of Hypoglycemic Agent Nateglinide with Decreased Hepatic Drug-Metabolizing Activity in Rats.
    Kojina M; Suzuki K; Nishiwaki A; Aiba T
    Biol Pharm Bull; 2021; 44(1):96-102. PubMed ID: 33390555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-drug and food-drug pharmacokinetic interactions with new insulinotropic agents repaglinide and nateglinide.
    Scheen AJ
    Clin Pharmacokinet; 2007; 46(2):93-108. PubMed ID: 17253883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacokinetics of nateglinide: a rapidly-absorbed, short-acting insulinotropic agent.
    McLeod JF
    Clin Pharmacokinet; 2004; 43(2):97-120. PubMed ID: 14748619
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.